Amlodipine Cost in Minnesota 2026

What Does Amlodipine Cost in Minnesota in 2026?

Generic amlodipine is one of the most affordable prescription drugs in Minnesota. At retail pharmacies across the state, the average cash-pay price sits at approximately $8 per month in 2026, with some discount programs bringing it below $5. Pfizer's brand-name Norvasc carries a list price near $80 per month, though few patients pay that amount because generics have dominated the market since 2007.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved it for hypertension and angina, and it remains a first-line agent in the 2023 ACC/AHA Hypertension Guidelines [1]. Its cardiovascular benefit was established in the ASCOT-BPLA trial (N=19,257), which compared amlodipine-based therapy to atenolol-based therapy and found that the amlodipine arm reduced fatal and non-fatal strokes by 23% (P<0.0001) over a median follow-up of 5.5 years [2].

The price gap between brand and generic in Minnesota is stark. A patient paying full cash price at a major chain pharmacy can expect to pay $8 to $15 per month for the generic 5 mg or 10 mg tablet. GoodRx coupons and similar tools routinely push that below $10 even without insurance. The Norvasc brand, still listed at roughly $80 per month, is almost never dispensed without a specific brand-required prescription because the generic is therapeutically equivalent under Minnesota pharmacy substitution law.

Doses prescribed most often in clinical practice are 5 mg once daily as a starting dose and 10 mg once daily as the maintenance target for most adults. Patients with hepatic impairment or elderly patients may start at 2.5 mg to reduce the risk of peripheral edema, the most common side effect reported in trials at rates of 10.8% for 10 mg versus 0.6% for placebo [3].

How Minnesota Medicaid (Medical Assistance) Covers Amlodipine

Minnesota Medicaid, called Medical Assistance (MA), covers amlodipine but requires prior authorization (PA) in many circumstances. That PA requirement is not unusual for a generic antihypertensive on a tiered formulary.

The Minnesota Department of Human Services (DHS) places most generic calcium channel blockers on the preferred drug list (PDL), but coverage details vary by managed care organization (MCO). Enrollees in UCare, Blue Plus, Hennepin Healthcare, or South Country Health Alliance should verify formulary tier and PA requirements directly with their plan. The PA process for amlodipine typically involves documentation of the patient's blood pressure diagnosis (ICD-10 I10 or I20.x for angina) and, in some cases, confirmation that a formulary-preferred beta-blocker or ACE inhibitor was considered first.

For patients fully enrolled in fee-for-service Medical Assistance rather than an MCO, the DHS Pharmacy Program covers amlodipine at the lowest available acquisition cost. Out-of-pocket co-pays under MN MA are capped at $3 per prescription for most beneficiaries. Patients who qualify for both Medicare and Medicaid (dual eligibles) usually obtain amlodipine through their Part D plan with a $0 or $1 co-pay under the Low Income Subsidy (LIS) program [4].

"Thiazide diuretics, ACE inhibitors, ARBs, and calcium channel blockers are all recommended as initial antihypertensive therapy in most patients," states the 2023 ACC/AHA Hypertension Writing Committee [1]. That guideline endorsement means Medicaid PA reviewers should expect amlodipine requests to meet medical necessity criteria without difficulty in most standard hypertension cases.

Compounded Amlodipine in Minnesota: What Is Legal?

Compounded amlodipine is legal in Minnesota when prepared by a licensed 503A pharmacy operating under a valid patient-specific prescription. The $0 cost figure sometimes cited reflects specific compounding programs where the pharmacy's dispensing fee is covered by a manufacturer coupon, patient assistance program, or employer health plan, not a universal price point.

Under federal law (21 U.S.C. § 503A), a 503A compounding pharmacy may prepare amlodipine for an individual patient when a licensed prescriber writes a prescription. Minnesota Board of Pharmacy rules require the compounding pharmacy to hold an active MN pharmacy license and comply with USP Chapter 795 standards for non-sterile compounding. The FDA has not placed amlodipine on the Demonstrably Difficult to Compound list or the Drug Shortage list at the time of this writing, which means 503A compounding is permissible [5].

Why would someone pursue a compounded formulation when the generic tablet costs $8 per month? Three main reasons arise in clinical practice. First, patients with swallowing difficulties may need an oral suspension. Second, some combination compounding protocols pair amlodipine with another antihypertensive in a single capsule to reduce pill burden. Third, certain direct-primary-care (DPC) or telehealth platforms negotiate compounding relationships that yield $0 out-of-pocket cost to the patient as part of a membership model.

Patients should verify that any compounding pharmacy they use is licensed by the Minnesota Board of Pharmacy, which maintains a public license-lookup tool at mn.gov/boards/pharmacy. 503B outsourcing facilities, which produce sterile bulk product for hospitals, are generally not the source for individual oral amlodipine prescriptions.

HealthRX Compounding Decision Framework for Amlodipine in Minnesota

| Patient Situation | Recommended Path | Estimated Monthly Cost | |---|---|---| | Standard adult with hypertension, no swallowing issues | Generic tablet via retail pharmacy | $8 | | Patient enrolled in MN Medicaid MA | Generic via MA with PA | $0 to $3 co-pay | | Patient in DPC or telehealth membership plan | Compounded suspension or capsule via 503A partner | $0 to $15 | | Patient needing oral suspension (pediatric or dysphagia) | Compounded oral suspension via licensed 503A MN pharmacy | $15 to $40 | | Dual Medicare/Medicaid eligible with LIS | Part D with LIS | $0 to $1 |

Does Insurance Cover Amlodipine in Minnesota?

Nearly every commercial insurance plan covering prescriptions in Minnesota includes generic amlodipine on its formulary. The drug's long generic history, wide guideline endorsement, and low acquisition cost make formulary exclusion essentially nonexistent at the state level.

Under the Minnesota Comprehensive Health Association (MCHA) individual market plans and ACA marketplace plans sold through MNsure, generic amlodipine typically lands on Tier 1 (preferred generic), with co-pays ranging from $0 to $10 per month depending on the plan design. BlueCross BlueShield of Minnesota, Medica, HealthPartners, and PreferredOne all list amlodipine on Tier 1 in their 2026 formularies for most plan types, though members should always confirm on their specific plan's drug list before filling.

Employer-sponsored plans in Minnesota follow a similar pattern. A 2024 KFF Employer Health Benefits Survey found that among employer plans with three or more drug tiers, generic drugs average a $7 co-pay per fill at 30-day supply [6]. Amlodipine, as a Tier 1 generic, often comes in at or below that average.

For uninsured or underinsured Minnesotans, the $4 to $10 generic amlodipine pricing at major chains (Walgreens, CVS, Target/CVS, Cub Pharmacy, Walmart) means insurance coverage may not produce meaningful savings over cash-pay with a discount card. GoodRx, RxSaver, and NeedyMeds consistently show prices under $10 at multiple MN locations.

Pfizer Savings Card and Generic Manufacturer Discounts

Pfizer's Norvasc is rarely prescribed in Minnesota in 2026 given the strong generic market, but Pfizer does maintain a savings card program for commercially insured patients who receive the brand for a specific clinical reason. The card historically reduces the out-of-pocket cost to $0 to $20 per month for eligible patients. It cannot be combined with federal or state government insurance programs, including Minnesota Medicaid or Medicare Part D.

For generic amlodipine, manufacturer-level savings cards do not exist in the same form. The cost-reduction mechanisms are different: pharmacy discount programs (GoodRx, Blink Health, Costco Pharmacy membership pricing), state pharmaceutical assistance, and low-income subsidy programs. Costco Pharmacy in Minnesota routinely offers 90-day supplies of generic amlodipine for under $15, which works out to about $5 per month without any discount card.

The 340B Drug Pricing Program allows qualifying safety-net clinics and federally qualified health centers (FQHCs) in Minnesota to acquire amlodipine at sub-wholesale prices and pass those savings to uninsured or low-income patients. Hennepin Healthcare, NorthPoint Health and Wellness, and Open Cities Health Center participate in 340B; patients seen there may obtain amlodipine at no cost or nominal cost [7].

Telehealth Prescribing of Amlodipine in Minnesota

Minnesota law permits telehealth prescribing of amlodipine by a licensed Minnesota prescriber following a valid patient-physician relationship established through synchronous audio-video technology or, in some circumstances, asynchronous evaluation with appropriate clinical documentation. The Minnesota Telehealth Act (Minn. Stat. § 62A.671) requires commercial insurers to cover telehealth services at parity with in-person visits [8].

A telehealth visit for blood pressure management typically costs $50 to $150 without insurance and $0 to $30 with insurance under parity rules. Given that generic amlodipine itself costs about $8 per month, the total first-month cost via telehealth (visit plus medication) may run $58 to $160, with subsequent months costing only the prescription fill.

Prescribers must perform a clinically adequate evaluation before initiating amlodipine. That evaluation should include a review of baseline blood pressure readings (home monitoring or in-office), a medication history to screen for drug interactions (notably CYP3A4 inhibitors such as clarithromycin and ketoconazole, which can increase amlodipine plasma levels by 40% to 60%), and assessment of contraindications [9]. Cardiogenic shock is the primary absolute contraindication listed in the FDA-approved prescribing information [5].

Remote blood pressure monitoring devices, which many telehealth platforms provide or recommend, have validated accuracy under ISO 81060-2 standards. The combination of telehealth prescribing and a validated home monitor has been shown to improve blood pressure control compared to usual care in a 12-month randomized study (N=450, SBP reduction 10.7 mmHg vs. 6.3 mmHg, P<0.001) [10].

Clinical Background: Why Amlodipine Is Prescribed

Understanding the drug helps patients ask better questions about coverage and cost. Amlodipine blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac tissue, causing arterial vasodilation and a reduction in systemic vascular resistance. The result is a lowering of both systolic and diastolic blood pressure within 6 to 12 hours of the first dose, with peak effect at 6 to 12 hours and a plasma half-life of 30 to 50 hours that supports once-daily dosing [5].

The ASCOT-BPLA trial remains the most cited outcomes trial for amlodipine. In 19,257 patients with hypertension and at least three cardiovascular risk factors, amlodipine-based therapy (with perindopril added if needed) reduced all-cause mortality by 11% compared to atenolol-based therapy (P=0.0247) over 5.5 years [2]. That mortality benefit and the drug's proven tolerability profile explain its persistent place on every major guideline's first-line list.

For chronic stable angina, amlodipine reduces the frequency of anginal episodes by dilating coronary arteries and reducing cardiac oxygen demand. In the CAMELOT trial (N=1,997), amlodipine 10 mg daily over 24 months significantly reduced the rate of cardiovascular events compared to placebo (hazard ratio 0.69 to 95% CI 0.54 to 0.88, P=0.003) in patients with angiographically confirmed coronary artery disease and normal blood pressure [11].

Peripheral edema, the most patient-reported adverse effect, is dose-dependent. At 5 mg, edema occurs in about 3% of patients. At 10 mg, the rate rises to approximately 10.8% [3]. Switching to an ARB-based combination or dose reduction often resolves it without abandoning the drug class.

Minnesota-Specific Resources and Next Steps

Minnesotans with cost concerns have several concrete options. The Minnesota Rx Connect program (administered by DHS) connects residents to manufacturer patient assistance programs, including those run by Viatris, which markets a generic amlodipine and maintains a patient assistance program for uninsured patients below 200% of the federal poverty level [12]. Applications are available through NeedyMeds.org and the manufacturer directly.

Area Agency on Aging offices across Minnesota help adults 60 and older enroll in Medicare Extra Help (LIS) for Part D drug costs, which can reduce amlodipine to $0 to $1 per fill. The Minnesota Senior LinkAge Line (1-800-333-2433) provides free navigation for this enrollment.

Patients with private insurance who face unexpected PA denials for amlodipine have external review rights under Minnesota law. A denial must include written notice of the appeal process, and insurers must respond to expedited appeals within 72 hours for urgent cases under Minn. Stat. § 62Q.73 [8].

For patients starting amlodipine through a telehealth platform, the standard monitoring protocol after initiation calls for a follow-up blood pressure assessment at 2 to 4 weeks, dose titration to 10 mg if the 5 mg starting dose does not achieve a target below 130/80 mmHg (per the 2023 ACC/AHA threshold for high cardiovascular-risk patients), and an annual renal function panel given the drug's renal-sparing but not renal-protective profile [1].